Condition

Squamous Cell Carcinoma of Head and Neck (SCCHN) clinical trials and research

• 2Clinical trials
• 1New in 30 days
• 2Countries

All recruiting trials (2)

• TMV vaccine alone or with toripalimab for recurrent head and neck cancer

  This study tests a personalized TMV vaccine, alone and with toripalimab, in adults whose head and neck cancer has returned and is planning salvage surgery.

  Recruiting Phase 1 Metaclipse Therapeutics Corporation · Houston, Texas · NCT07898124

• Ficerafusp alfa with nivolumab in platinum-refractory head and neck cancer

  This study tests whether adding ficerafusp alfa to nivolumab helps patients with head and neck squamous cell cancer that progressed after platinum therapy.

  Recruiting Phase 2 Groupe Oncologie Radiotherapie Tete et Cou · Villejuif · NCT07529873

Related topics

Quick answers

How many Squamous Cell Carcinoma of Head and Neck (SCCHN) clinical trials are recruiting right now?

2, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in United States (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →